Latest filing published 07 Jan 2026 for Biohaven Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
George C. Clark is a declared insider at 2 companies (senior executive); the most frequent names are Biohaven Pharmaceutical Holding Co Ltd. and Biohaven Ltd. Over a trading history stretching from 23 November 2021 to 5 January 2026, the count stands at 10 filings.
The open-market side counts 1 purchase for €125k alongside 1 sale for €211k. Sales outweigh purchases by €86k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 option exercises.
Most recently, on 7 January 2026, the filings show an option exercise in Biohaven Ltd. The last insider purchase was made public on 18 November 2025, 334 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations